Heart disease is the leading cause of maternal death in the U.S., yet research on how to improve care for pregnant individuals with cardiovascular disease remains limited. The Heart Outcomes in Pregnancy Expectations (HOPE) for Mom and Baby study aims to change that. Saint Luke's cardiologists Dr. John Spertus and Dr. Anna Grodzinsky spearhead this groundbreaking study alongside UMKC through the Healthcare Institute for Innovations in Quality. We are proud to collaborate with UMKC, Kansas City's first Carnegie Research 1 (R1) institution, to expand the boundaries of what's possible for healthier cardiovascular outcomes for mothers and their babies. Congratulations to UMKC on this prestigious honor! 💙 (fb)

Type 2 diabetes is strongly linked to obesity in both adults and children. People living with Type 2 diabetes are more prone to heart-related issues—that’s why Saint Luke’s launched the Michael & Marlys Haverty Cardiometabolic Center of Excellence, designed specifically to help with heart complications in patients with diabetes. New medications and treatments are providing newer and better options for managing these conditions. Learn about it from Melissa Magwire, program director of Saint Luke’s Cardiometabolic Center Alliance, on Health News You Can Use. (fb)